Shockwave Therapy for Plantar Fasciitis in Chicago: Research-Backed Results

Plantar fasciitis is the most common cause of heel pain, affecting an estimated 2 million Americans each year. The condition develops when the plantar fascia — the thick band of connective tissue that runs along the bottom of the foot from the heel bone to the toes — becomes chronically inflamed and undergoes degenerative changes at its insertion point on the calcaneus. The result is stabbing heel pain that is typically worst with the first steps in the morning or after periods of rest, a pattern known as post-static dyskinesia.

For most patients, plantar fasciitis resolves within 6–12 months with conservative treatment: stretching, orthotics, anti-inflammatory medication, and activity modification. But for the 10–20% of patients whose pain persists beyond 3 months despite these measures, extracorporeal shockwave therapy (ESWT) offers a non-surgical path to lasting relief — and one of the strongest clinical evidence bases of any musculoskeletal treatment option.

At Michigan Avenue Podiatry, Dr. Mohammad Usman, DPM performs ESWT for chronic plantar fasciitis at our Chicago office. Dr. Usman evaluates each patient with diagnostic ultrasound before recommending shockwave therapy, ensuring the procedure is matched to the specific pattern of fascial degeneration identified on imaging. ESWT is offered as a cash-pay procedure. Contact us at (312) 701-0770 to discuss pricing and whether ESWT is right for your heel pain.

Schedule a Plantar Fasciitis Consultation

Dr. Mohammad Usman, DPM offers ESWT for chronic heel pain at our Michigan Avenue Chicago office. Cash-pay procedure — no surgery, no injections.

Book a ConsultationCall (312) 701-0770

What the Research Says About ESWT for Plantar Fasciitis

Shockwave therapy for plantar fasciitis is among the most well-studied applications of ESWT in podiatric medicine. The clinical evidence is consistent across multiple independent research groups and study designs spanning more than two decades.

A landmark 2017 meta-analysis in the Journal of Orthopaedic Surgery and Research found that ESWT significantly improves heel pain compared to placebo in patients with chronic plantar fasciitis, with the benefit persisting and deepening at 3-, 6-, and 12-month follow-up assessments (PubMed 27977431). A separate 2022 randomized controlled trial comparing ESWT directly to ultrasound therapy found ESWT was superior for both pain reduction and functional improvement at all measured time points (PubMed 35145778).

A comprehensive 2024 meta-analysis covering 45 controlled studies across tendinopathy and soft tissue conditions confirmed significant pain reduction with ESWT as a class of treatment (PMC11041007), with plantar fasciitis consistently among the conditions demonstrating the strongest treatment response. Additional research has explored the cellular mechanisms: a 2020 laboratory study confirmed that ESWT upregulates TGF-β1 and VEGF in human plantar fascia fibroblasts, directly stimulating the collagen synthesis and neovascularization pathways underlying clinical improvement.

Pooled clinical data shows that 60–80% of patients with chronic plantar fasciitis achieve significant and lasting pain relief following a standard 3–5 session ESWT course. These outcomes compare favorably to cortisone injections (effective short-term but associated with plantar fascia rupture risk with repeated use) and are achieved without surgery, downtime, or anesthesia.

The American College of Foot and Ankle Surgeons (ACFAS) includes ESWT among its recommended treatment modalities for plantar fasciitis that has not responded to a minimum of 3 months of conservative care, reflecting the procedure’s established safety and efficacy profile.

How ESWT Works for Plantar Fasciitis: The Biology

Chronic plantar fasciitis is not simply an inflammatory condition — pathology studies of the plantar fascia in affected patients reveal fasciosis (degenerative change) rather than acute inflammation: disorganized collagen fibers, tenocyte degeneration, and fatty infiltration of the fascial tissue. This is why anti-inflammatory treatments like cortisone injections often provide only temporary relief — they do not address the underlying degenerative process.

ESWT works through a fundamentally different mechanism. When acoustic waves are delivered to the plantar fascia insertion, the resulting controlled microtrauma initiates a true healing cascade:

  • Neovascularization: New capillary formation restores blood supply and nutrient delivery to the chronically hypovascular degenerated tissue
  • Growth factor upregulation: Release of TGF-β1, VEGF, and PDGF activates fibroblast proliferation and new collagen synthesis
  • Neocollagenesis: New, organized type I collagen fibers are deposited to replace the degraded fascial matrix
  • Substance P depletion: Reduction in the neuropeptide substance P in local sensory nerves provides direct analgesic effects beyond tissue healing
  • Calcification dissolution: In cases with calcium deposits within the fascial tissue, ESWT can help disperse these deposits over time

The net effect is structural regeneration of the damaged plantar fascia rather than temporary symptom suppression — which explains why ESWT’s outcomes are more durable than cortisone injections and improve over weeks to months following treatment.

Is ESWT Right for Your Heel Pain?

Dr. Mohammad Usman, DPM reviews your imaging and history before recommending shockwave therapy. Call or book online to schedule your evaluation.

Book a ConsultationCall (312) 701-0770

Who Is a Good Candidate for Shockwave Therapy?

Dr. Mohammad Usman typically recommends ESWT for plantar fasciitis when patients meet these criteria:

  • Plantar fasciitis symptoms present for 3 months or longer
  • Inadequate relief from conservative treatment (stretching, custom orthotics, NSAIDs, physical therapy, night splints)
  • No complete plantar fascia tear on diagnostic ultrasound or MRI imaging
  • No active infection, open wound, or blood clotting disorder in the treatment area
  • Preference for a non-surgical, non-injection treatment approach
  • Unable or unwilling to take extended time off for surgical recovery (partial plantar fascia release requires several weeks of protected weight-bearing)

ESWT is not indicated in the presence of active infection, open wounds in the treatment area, blood clotting disorders, or certain systemic conditions. A complete evaluation — including diagnostic imaging to rule out fascial tear — is performed before treatment is recommended by Dr. Usman.

What Does ESWT Feel Like for Plantar Fasciitis?

Before each session, ultrasound gel is applied to the heel and arch. The shockwave applicator is then placed against the skin and moved slowly over the plantar fascia insertion and surrounding tissue while delivering focused acoustic pulses. Dr. Usman uses real-time diagnostic ultrasound guidance at evaluation to precisely map the area of maximum fascial thickening and degeneration, ensuring the applicator is positioned accurately during treatment.

Patients typically describe the sensation as a tapping or vibrating pressure, with brief sharp intensity when the probe is directly over the most inflamed area of the plantar fascia insertion. This discomfort — usually rated 3–5 out of 10 — is expected and clinically meaningful: it indicates that the shockwaves are reaching the target tissue. Sessions last 15–20 minutes. No anesthesia is required. Most patients walk comfortably out of the office immediately after treatment in their regular shoes.

Treatment Course and Recovery Timeline

A standard ESWT course for plantar fasciitis consists of 3–5 sessions spaced one week apart. Between sessions, low-impact activity can continue — most patients maintain their regular daily routine throughout treatment. High-impact activity (running, jumping, prolonged standing) should be avoided for 24–48 hours after each session to allow the tissue healing response to proceed without mechanical disruption.

Some temporary soreness in the heel for 24–48 hours after each session is normal and is part of the tissue remodeling process — it should not be confused with the original plantar fasciitis worsening. Most patients begin to notice meaningful improvement in their heel pain starting in weeks 2–3 of the treatment course.

The full therapeutic effect of ESWT continues to develop over 6–12 weeks as neovascularization and collagen remodeling progress in the plantar fascia. Clinical studies consistently report that outcomes continue to improve through 3- and 6-month follow-up assessments. At 12-month follow-up, 60–80% of patients maintain significant pain relief without additional intervention — making ESWT one of the most durable non-surgical options available for chronic heel pain.

Shockwave Therapy for Plantar Fasciitis at Michigan Avenue Podiatry

Michigan Avenue Podiatry offers ESWT for plantar fasciitis at our Chicago office at 30 North Michigan Avenue, Suite 1220. Dr. Mohammad Usman, DPM evaluates each patient with a complete examination and, when indicated, diagnostic ultrasound before recommending shockwave therapy. This ensures the treatment plan is matched to your specific pattern of injury.

ESWT is offered as a cash-pay procedure at our practice. This is a procedure Dr. Usman performs in-office — no hospital visit, no anesthesiologist, no surgical facility fee. Contact us to discuss pricing and determine whether shockwave therapy is the right option for your heel pain. Call (312) 701-0770 or book an appointment online. For a complete overview of shockwave therapy at MAP, see our shockwave treatment hub page.

Book Your ESWT Consultation Today

Dr. Mohammad Usman, DPM treats chronic plantar fasciitis with shockwave therapy at our Chicago office. Cash-pay procedure — contact us to discuss pricing.

Book a ConsultationCall (312) 701-0770

Frequently Asked Questions

Is shockwave therapy for plantar fasciitis painful?
Most patients experience mild to moderate discomfort during treatment, which is expected and indicates the waves are reaching the target tissue. The sensation is typically described as tapping or vibrating pressure, rated 3–5 out of 10. No anesthesia is required. Post-treatment soreness for 24–48 hours is normal and part of the healing process.

How many shockwave therapy sessions are needed for plantar fasciitis?
Most protocols call for 3–5 sessions spaced 1 week apart. Some patients notice significant improvement after 2–3 sessions; others benefit from the full course. The tissue healing and remodeling process continues for 6–12 weeks after the final session.

How does ESWT compare to cortisone injections for heel pain?
Cortisone injections reduce inflammation quickly but do not stimulate tissue repair and carry risks including plantar fascia rupture with repeated use. ESWT works more slowly but promotes actual structural healing of the fascial tissue, with outcomes that continue to improve over months and are more durable at 12-month follow-up.

Is shockwave therapy covered by insurance for plantar fasciitis?
Coverage varies by insurance plan. ESWT is offered as a cash-pay procedure at Michigan Avenue Podiatry. Dr. Usman’s team will review costs during your consultation at (312) 701-0770. We can provide documentation to help you seek reimbursement from your insurer if your plan covers it.

Can I still walk and work while undergoing ESWT treatment?
Yes. ESWT does not require downtime. Most patients continue their regular daily activities — including work and light walking — throughout the treatment course. High-impact activity should be reduced for 24–48 hours after each session, but there is no period of non-weight-bearing or restricted activity.

Medical Disclaimer This content is provided for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Results vary by patient and individual medical circumstances. Extracorporeal Shock Wave Therapy (ESWT) outcomes, recovery timelines, and patient suitability depend on factors unique to each individual and can only be determined through an in-person evaluation with a licensed physician. Nothing on this website should be interpreted as a guarantee of results or a promise of symptom resolution. Always consult a qualified, licensed healthcare provider before beginning any treatment program. Michigan Avenue Podiatry and Dr. Mohammad Usman, DPM are not liable for actions taken based on information published on this website without direct clinical evaluation.

Dr. Mohammad Usman, DPM

Dr. Mohammad Usman, DPM is a board-eligible Podiatric Physician and Foot & Ankle Surgeon, and Founder of Michigan Avenue Podiatry Clinic. He completed his Doctor of Podiatric Medicine at Rosalind Franklin University of Medicine and Science and his residency in Podiatric Surgery at Weiss Memorial Hospital. Dr. Usman has advanced training in Podiatric Medicine, Surgery, and Reconstructive Rearfoot/Ankle Surgery. He has been featured in Forbes, CNN, The Wall Street Journal, Bustle, and Medscape for his expertise in minimally invasive foot and ankle care. He serves patients across four Chicagoland locations: Downtown Chicago, Elmhurst, Flossmoor, and Tinley Park.

Leave a Reply